Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA study
- 1 August 1990
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 38 (2) , 203-209
- https://doi.org/10.1016/0090-8258(90)90042-j
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The treatment of advanced ovarian carcinoma (II): Interval reassessment operations during chemotherapyGynecologic Oncology, 1988
- A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinomaGynecologic Oncology, 1987
- Cytoreductive Surgery in Ovarian CarcinomaObstetrics & Gynecology, 1986
- The potential for optimal (⩽ 2 cm) cytoreductive surgery in advanced ovarian carcinoma at a tertiary medical center: A prospective studyGynecologic Oncology, 1986
- Second-look laparotomy in ovarian cancer: Evaluation of pathologic variablesAmerican Journal of Obstetrics and Gynecology, 1985
- RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1984
- Long-term survival after chemotherapy for advanced epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1984
- CARCINOMA OF THE OVARY, STAGE-I AND STAGE-II - A PROSPECTIVE RANDOMIZED STUDY OF THE EFFECTS OF POSTOPERATIVE CHEMOTHERAPY AND RADIOTHERAPY1982